SlideShare una empresa de Scribd logo
1 de 20
[object Object]
 The major causes of inter subject pharmacokinetic  variability are  :- 	,[object Object]
Age          1.Drug metabolism in new born        2.Plasma protein bonding in new born        3.Renal excretion in new born        4.Drug metabolism in children ,[object Object]
Disease,[object Object]
[object Object]
Drug binding, metabolism, and excretion may change as a function of age.
The study panel was divided into 5 groups:                        		              Newborns (2 to 3 days) 	          Infants (1 to 12 months)               Children (4 to 9 years)                Adults (16 to 37 years)                Elderly subjects (more than 70 years)
[object Object]
Clearance increased from 0.9 to 2.5 ml/min. when comparing patient 1 to 8 days old with patient 9 to 30  days old.
The mean clearance of ceftriaxone in children ranging in age from 1 to 12 months and from 1 to 6 years was 6.2 ml/min. and 9.1 ml/min. respectively.
The  18 to 49 years old age group had the highest clearance of ceftriaxone, 17 ml/min. ,[object Object]
Very elderly patients 75 to 92 years of age had an average clearance of about 8 ml/min.,[object Object]
Most of the enzymatic microsomal systems required for drug metabolism are present at birth, but their  concentration are usually lower than adult levels.
In  general drugs subject to  biotransformation are eliminated more slowly in newborn than in adult.,[object Object]
Sulfate conjugation seems to be as efficient in newborns as in adults, but conjugation with glucuronic acid is considerably reduced, reaching adult level only after 3 years of age.
This deficiency is responsible for the serious adverse effects observed in newborn after administration of chloramphenicol a drug that is ordinarily conjugated with glucuroni acid.  ,[object Object]
The amount of unchanged theophylline in urine in premature infants decreases with postnatal age, whereas the excretion of metabolites increases with age. ,[object Object]
In each case binding in plasma protein is level in the newborns than in the adults.
Increase in plasma protein binding is an increase in apparent volume of distribution in the newborn.

Más contenido relacionado

La actualidad más candente

Dose adjustment in renal disease
Dose adjustment in renal diseaseDose adjustment in renal disease
Dose adjustment in renal diseaseAreej Abu Hanieh
 
General Introduction on therapeutic drug monitoring
General Introduction on therapeutic drug monitoringGeneral Introduction on therapeutic drug monitoring
General Introduction on therapeutic drug monitoringDr. Ramesh Bhandari
 
Relationship between pharmacokinetics and pharmacodynamics.pptx
Relationship between pharmacokinetics and pharmacodynamics.pptxRelationship between pharmacokinetics and pharmacodynamics.pptx
Relationship between pharmacokinetics and pharmacodynamics.pptxMdHimelAhmedRidoy1
 
Geriatric,obese and pediatric patients Pharmacokinetics
Geriatric,obese and pediatric patients PharmacokineticsGeriatric,obese and pediatric patients Pharmacokinetics
Geriatric,obese and pediatric patients PharmacokineticsAreej Abu Hanieh
 
TDM of drugs used in cardiovascular diseases
TDM of drugs used in cardiovascular diseasesTDM of drugs used in cardiovascular diseases
TDM of drugs used in cardiovascular diseasesDr. Ramesh Bhandari
 
Individualisation and optimization of drug dosing regimen
Individualisation and optimization of drug dosing regimenIndividualisation and optimization of drug dosing regimen
Individualisation and optimization of drug dosing regimenJyoti Nautiyal
 
Effects of liver diseases on pharmacokinetics
Effects of liver diseases on pharmacokineticsEffects of liver diseases on pharmacokinetics
Effects of liver diseases on pharmacokineticsDr. Ramesh Bhandari
 
Effects of liver diseases on pharmacokinetics
Effects of liver diseases on pharmacokineticsEffects of liver diseases on pharmacokinetics
Effects of liver diseases on pharmacokineticsDr. Ramesh Bhandari
 
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimenconversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimenpavithra vinayak
 
Pharmacokinetic and pharmacodynamic correlation
Pharmacokinetic and pharmacodynamic correlationPharmacokinetic and pharmacodynamic correlation
Pharmacokinetic and pharmacodynamic correlationDr. Ramesh Bhandari
 
clinical pharmacokinetics
clinical pharmacokineticsclinical pharmacokinetics
clinical pharmacokineticsmubarek ahmedin
 
Drug distribution and elimination
Drug distribution and eliminationDrug distribution and elimination
Drug distribution and eliminationDr Roohana Hasan
 
Individualization of dosage regimen
Individualization of dosage regimenIndividualization of dosage regimen
Individualization of dosage regimenPARUL UNIVERSITY
 

La actualidad más candente (20)

Dosing in obese patient
Dosing in obese patientDosing in obese patient
Dosing in obese patient
 
Dose adjustment in renal disease
Dose adjustment in renal diseaseDose adjustment in renal disease
Dose adjustment in renal disease
 
General Introduction on therapeutic drug monitoring
General Introduction on therapeutic drug monitoringGeneral Introduction on therapeutic drug monitoring
General Introduction on therapeutic drug monitoring
 
Relationship between pharmacokinetics and pharmacodynamics.pptx
Relationship between pharmacokinetics and pharmacodynamics.pptxRelationship between pharmacokinetics and pharmacodynamics.pptx
Relationship between pharmacokinetics and pharmacodynamics.pptx
 
Geriatric,obese and pediatric patients Pharmacokinetics
Geriatric,obese and pediatric patients PharmacokineticsGeriatric,obese and pediatric patients Pharmacokinetics
Geriatric,obese and pediatric patients Pharmacokinetics
 
TDM of drugs used in cardiovascular diseases
TDM of drugs used in cardiovascular diseasesTDM of drugs used in cardiovascular diseases
TDM of drugs used in cardiovascular diseases
 
Individualisation and optimization of drug dosing regimen
Individualisation and optimization of drug dosing regimenIndividualisation and optimization of drug dosing regimen
Individualisation and optimization of drug dosing regimen
 
Dosage regimen
Dosage regimenDosage regimen
Dosage regimen
 
Effects of liver diseases on pharmacokinetics
Effects of liver diseases on pharmacokineticsEffects of liver diseases on pharmacokinetics
Effects of liver diseases on pharmacokinetics
 
Effects of liver diseases on pharmacokinetics
Effects of liver diseases on pharmacokineticsEffects of liver diseases on pharmacokinetics
Effects of liver diseases on pharmacokinetics
 
Clinical pharmacokinetics
Clinical pharmacokineticsClinical pharmacokinetics
Clinical pharmacokinetics
 
Dosing in childrens
Dosing in childrensDosing in childrens
Dosing in childrens
 
Multiple Dosage regimen
Multiple Dosage regimenMultiple Dosage regimen
Multiple Dosage regimen
 
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimenconversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
 
Pharmacokinetic and pharmacodynamic correlation
Pharmacokinetic and pharmacodynamic correlationPharmacokinetic and pharmacodynamic correlation
Pharmacokinetic and pharmacodynamic correlation
 
clinical pharmacokinetics
clinical pharmacokineticsclinical pharmacokinetics
clinical pharmacokinetics
 
Hepatic clearance and elimination
Hepatic clearance and eliminationHepatic clearance and elimination
Hepatic clearance and elimination
 
Drug distribution and elimination
Drug distribution and eliminationDrug distribution and elimination
Drug distribution and elimination
 
Individualization of dosage regimen
Individualization of dosage regimenIndividualization of dosage regimen
Individualization of dosage regimen
 
Pharmacokinetics ppt
Pharmacokinetics pptPharmacokinetics ppt
Pharmacokinetics ppt
 

Destacado

Applications of pharmacokinetics parameters in disease states
Applications of pharmacokinetics parameters in disease statesApplications of pharmacokinetics parameters in disease states
Applications of pharmacokinetics parameters in disease statesUmair hanif
 
Factors affecting pharmacokinetic parameters
Factors affecting pharmacokinetic parametersFactors affecting pharmacokinetic parameters
Factors affecting pharmacokinetic parametersJeffrey Pradeep Raj
 
Therapeutic Drug Monitoring
Therapeutic Drug MonitoringTherapeutic Drug Monitoring
Therapeutic Drug MonitoringTulasi Raman
 
Trouble Shooting of Chemical Process Industry
Trouble Shooting of Chemical Process IndustryTrouble Shooting of Chemical Process Industry
Trouble Shooting of Chemical Process IndustryPankaj Khandelwal
 
Pharmacokinetic changes of drugs in hepatic diseases
Pharmacokinetic changes of drugs in hepatic diseasesPharmacokinetic changes of drugs in hepatic diseases
Pharmacokinetic changes of drugs in hepatic diseasesDr Htet
 
Pharmacokinetics In Special Populations
Pharmacokinetics In Special PopulationsPharmacokinetics In Special Populations
Pharmacokinetics In Special Populationspccampo
 
Pharmacokinetics (updated 2011) - drdhriiti
Pharmacokinetics (updated 2011)  - drdhriitiPharmacokinetics (updated 2011)  - drdhriiti
Pharmacokinetics (updated 2011) - drdhriitihttp://neigrihms.gov.in/
 
35 effects of renal disease on pharmacokinetics
35 effects of renal disease on pharmacokinetics35 effects of renal disease on pharmacokinetics
35 effects of renal disease on pharmacokineticsDang Thanh Tuan
 
Design and optimizing of dosage regimen - pharmacology
Design and optimizing of dosage regimen - pharmacology Design and optimizing of dosage regimen - pharmacology
Design and optimizing of dosage regimen - pharmacology Areej Abu Hanieh
 
Pilot plant scale up techniques used in pharmaceutical manufacturing
Pilot plant scale up techniques used in pharmaceutical manufacturingPilot plant scale up techniques used in pharmaceutical manufacturing
Pilot plant scale up techniques used in pharmaceutical manufacturingProf. Dr. Basavaraj Nanjwade
 
PK and Drug Therapy in pediatrics, geriatrics and pregnancy & Lactation
PK and Drug Therapy in pediatrics, geriatrics and pregnancy & LactationPK and Drug Therapy in pediatrics, geriatrics and pregnancy & Lactation
PK and Drug Therapy in pediatrics, geriatrics and pregnancy & LactationSreeja Saladi
 
Clinical pharmacology in special populations 2014
Clinical pharmacology in special populations 2014Clinical pharmacology in special populations 2014
Clinical pharmacology in special populations 2014vanessawhitehawk
 
DRUG-DOSE ADJUSTMENT IN PATIENTS WITH HEPATIC DISEASES
DRUG-DOSE ADJUSTMENT IN PATIENTS WITH HEPATIC DISEASESDRUG-DOSE ADJUSTMENT IN PATIENTS WITH HEPATIC DISEASES
DRUG-DOSE ADJUSTMENT IN PATIENTS WITH HEPATIC DISEASESDr.Amreen Saba Attariya
 

Destacado (20)

Applications of pharmacokinetics parameters in disease states
Applications of pharmacokinetics parameters in disease statesApplications of pharmacokinetics parameters in disease states
Applications of pharmacokinetics parameters in disease states
 
Obsity
ObsityObsity
Obsity
 
Factors affecting pharmacokinetic parameters
Factors affecting pharmacokinetic parametersFactors affecting pharmacokinetic parameters
Factors affecting pharmacokinetic parameters
 
Dosage Regimen
Dosage RegimenDosage Regimen
Dosage Regimen
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoring
 
Therapeutic Drug Monitoring
Therapeutic Drug MonitoringTherapeutic Drug Monitoring
Therapeutic Drug Monitoring
 
Trouble Shooting of Chemical Process Industry
Trouble Shooting of Chemical Process IndustryTrouble Shooting of Chemical Process Industry
Trouble Shooting of Chemical Process Industry
 
Pharmacokinetic changes of drugs in hepatic diseases
Pharmacokinetic changes of drugs in hepatic diseasesPharmacokinetic changes of drugs in hepatic diseases
Pharmacokinetic changes of drugs in hepatic diseases
 
Renal Clearance
Renal ClearanceRenal Clearance
Renal Clearance
 
Pharmacokinetics In Special Populations
Pharmacokinetics In Special PopulationsPharmacokinetics In Special Populations
Pharmacokinetics In Special Populations
 
Pharmacokinetics (updated 2011) - drdhriiti
Pharmacokinetics (updated 2011)  - drdhriitiPharmacokinetics (updated 2011)  - drdhriiti
Pharmacokinetics (updated 2011) - drdhriiti
 
35 effects of renal disease on pharmacokinetics
35 effects of renal disease on pharmacokinetics35 effects of renal disease on pharmacokinetics
35 effects of renal disease on pharmacokinetics
 
Design and optimizing of dosage regimen - pharmacology
Design and optimizing of dosage regimen - pharmacology Design and optimizing of dosage regimen - pharmacology
Design and optimizing of dosage regimen - pharmacology
 
Renal clearance
Renal clearanceRenal clearance
Renal clearance
 
Pilot plant scale up techniques used in pharmaceutical manufacturing
Pilot plant scale up techniques used in pharmaceutical manufacturingPilot plant scale up techniques used in pharmaceutical manufacturing
Pilot plant scale up techniques used in pharmaceutical manufacturing
 
excretion
excretionexcretion
excretion
 
PK and Drug Therapy in pediatrics, geriatrics and pregnancy & Lactation
PK and Drug Therapy in pediatrics, geriatrics and pregnancy & LactationPK and Drug Therapy in pediatrics, geriatrics and pregnancy & Lactation
PK and Drug Therapy in pediatrics, geriatrics and pregnancy & Lactation
 
Clinical pharmacology in special populations 2014
Clinical pharmacology in special populations 2014Clinical pharmacology in special populations 2014
Clinical pharmacology in special populations 2014
 
Pharmacokinetics of multiple dosing
Pharmacokinetics of multiple dosingPharmacokinetics of multiple dosing
Pharmacokinetics of multiple dosing
 
DRUG-DOSE ADJUSTMENT IN PATIENTS WITH HEPATIC DISEASES
DRUG-DOSE ADJUSTMENT IN PATIENTS WITH HEPATIC DISEASESDRUG-DOSE ADJUSTMENT IN PATIENTS WITH HEPATIC DISEASES
DRUG-DOSE ADJUSTMENT IN PATIENTS WITH HEPATIC DISEASES
 

Similar a Pharmacokinetic variability

Clinical Pharmacokinetics
Clinical PharmacokineticsClinical Pharmacokinetics
Clinical PharmacokineticsNausheen Fatima
 
Paediatric pharmaco-kinetics
Paediatric pharmaco-kinetics Paediatric pharmaco-kinetics
Paediatric pharmaco-kinetics Ahmad K
 
Analgesic in Pedo-Part 1.pptx
Analgesic in Pedo-Part 1.pptxAnalgesic in Pedo-Part 1.pptx
Analgesic in Pedo-Part 1.pptxDr.Vani Bais
 
Drug distribution in pediatrics
Drug distribution in pediatricsDrug distribution in pediatrics
Drug distribution in pediatricsNithin Jayan
 
Pediatric drug for clinical pharmacy student 1
Pediatric drug for clinical pharmacy student 1Pediatric drug for clinical pharmacy student 1
Pediatric drug for clinical pharmacy student 1Hussein Abdeldayem
 
Neonatal pediatric-pharmacology
Neonatal pediatric-pharmacologyNeonatal pediatric-pharmacology
Neonatal pediatric-pharmacologydunya
 
Drugs used in special age groups like children, elderly and preganancy
Drugs used in special age groups like children, elderly and preganancyDrugs used in special age groups like children, elderly and preganancy
Drugs used in special age groups like children, elderly and preganancyRoopali Somani
 
Individualization of drug dosage regimen
Individualization of drug dosage regimenIndividualization of drug dosage regimen
Individualization of drug dosage regimenDr. Ramesh Bhandari
 
Drug therapy-Neonates and pediatrics
Drug therapy-Neonates and pediatricsDrug therapy-Neonates and pediatrics
Drug therapy-Neonates and pediatricsTsegaye Melaku
 
Pediatric pharmacotherapy
Pediatric pharmacotherapyPediatric pharmacotherapy
Pediatric pharmacotherapyKaveh Kazemian
 
prescribing in paediatrics.pptx
prescribing in paediatrics.pptxprescribing in paediatrics.pptx
prescribing in paediatrics.pptxAraphaMvugalo
 
Drug use in paediatric & geriatric patients
Drug use in paediatric & geriatric patientsDrug use in paediatric & geriatric patients
Drug use in paediatric & geriatric patientsViraj Shinde
 
Clinical pharmacy age factors : Features of the Rational use of Medicines
Clinical pharmacy age factors : Features of the Rational use of MedicinesClinical pharmacy age factors : Features of the Rational use of Medicines
Clinical pharmacy age factors : Features of the Rational use of MedicinesEneutron
 
Pharmacology for pediatric anaesthesia [autosaved]
Pharmacology for pediatric anaesthesia [autosaved]Pharmacology for pediatric anaesthesia [autosaved]
Pharmacology for pediatric anaesthesia [autosaved]DeepakGupta825
 
Paediatric Pharmacology Part-2.pptx
Paediatric Pharmacology Part-2.pptxPaediatric Pharmacology Part-2.pptx
Paediatric Pharmacology Part-2.pptx65NidheeshKumarPraba
 
Clinical trial in special population final
Clinical trial in special population finalClinical trial in special population final
Clinical trial in special population finalanupam raghunath
 
paeds drug drug calculation and formulas
paeds drug drug calculation and formulaspaeds drug drug calculation and formulas
paeds drug drug calculation and formulasPriyankaAnthony4
 

Similar a Pharmacokinetic variability (20)

Clinical Pharmacokinetics
Clinical PharmacokineticsClinical Pharmacokinetics
Clinical Pharmacokinetics
 
Paediatric pharmaco-kinetics
Paediatric pharmaco-kinetics Paediatric pharmaco-kinetics
Paediatric pharmaco-kinetics
 
Drug therapy in children
Drug therapy in childrenDrug therapy in children
Drug therapy in children
 
Analgesic in Pedo-Part 1.pptx
Analgesic in Pedo-Part 1.pptxAnalgesic in Pedo-Part 1.pptx
Analgesic in Pedo-Part 1.pptx
 
Drug distribution in pediatrics
Drug distribution in pediatricsDrug distribution in pediatrics
Drug distribution in pediatrics
 
Pediatric drug for clinical pharmacy student 1
Pediatric drug for clinical pharmacy student 1Pediatric drug for clinical pharmacy student 1
Pediatric drug for clinical pharmacy student 1
 
Neonatal pediatric-pharmacology
Neonatal pediatric-pharmacologyNeonatal pediatric-pharmacology
Neonatal pediatric-pharmacology
 
Drugs used in special age groups like children, elderly and preganancy
Drugs used in special age groups like children, elderly and preganancyDrugs used in special age groups like children, elderly and preganancy
Drugs used in special age groups like children, elderly and preganancy
 
Individualization of drug dosage regimen
Individualization of drug dosage regimenIndividualization of drug dosage regimen
Individualization of drug dosage regimen
 
Individualization of drug
Individualization of drugIndividualization of drug
Individualization of drug
 
Drug therapy-Neonates and pediatrics
Drug therapy-Neonates and pediatricsDrug therapy-Neonates and pediatrics
Drug therapy-Neonates and pediatrics
 
Paediatrics
PaediatricsPaediatrics
Paediatrics
 
Pediatric pharmacotherapy
Pediatric pharmacotherapyPediatric pharmacotherapy
Pediatric pharmacotherapy
 
prescribing in paediatrics.pptx
prescribing in paediatrics.pptxprescribing in paediatrics.pptx
prescribing in paediatrics.pptx
 
Drug use in paediatric & geriatric patients
Drug use in paediatric & geriatric patientsDrug use in paediatric & geriatric patients
Drug use in paediatric & geriatric patients
 
Clinical pharmacy age factors : Features of the Rational use of Medicines
Clinical pharmacy age factors : Features of the Rational use of MedicinesClinical pharmacy age factors : Features of the Rational use of Medicines
Clinical pharmacy age factors : Features of the Rational use of Medicines
 
Pharmacology for pediatric anaesthesia [autosaved]
Pharmacology for pediatric anaesthesia [autosaved]Pharmacology for pediatric anaesthesia [autosaved]
Pharmacology for pediatric anaesthesia [autosaved]
 
Paediatric Pharmacology Part-2.pptx
Paediatric Pharmacology Part-2.pptxPaediatric Pharmacology Part-2.pptx
Paediatric Pharmacology Part-2.pptx
 
Clinical trial in special population final
Clinical trial in special population finalClinical trial in special population final
Clinical trial in special population final
 
paeds drug drug calculation and formulas
paeds drug drug calculation and formulaspaeds drug drug calculation and formulas
paeds drug drug calculation and formulas
 

Último

Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaVirag Sontakke
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementmkooblal
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxAvyJaneVismanos
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxOH TEIK BIN
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Celine George
 
internship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerinternship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerunnathinaik
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfUjwalaBharambe
 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitolTechU
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfMahmoud M. Sallam
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
Biting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfBiting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfadityarao40181
 

Último (20)

Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of India
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of management
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptx
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptx
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17
 
internship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerinternship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developer
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptx
 
9953330565 Low Rate Call Girls In Rohini Delhi NCR
9953330565 Low Rate Call Girls In Rohini  Delhi NCR9953330565 Low Rate Call Girls In Rohini  Delhi NCR
9953330565 Low Rate Call Girls In Rohini Delhi NCR
 
OS-operating systems- ch04 (Threads) ...
OS-operating systems- ch04 (Threads) ...OS-operating systems- ch04 (Threads) ...
OS-operating systems- ch04 (Threads) ...
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdf
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
Biting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfBiting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdf
 

Pharmacokinetic variability

  • 1.
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7. Drug binding, metabolism, and excretion may change as a function of age.
  • 8. The study panel was divided into 5 groups: Newborns (2 to 3 days) Infants (1 to 12 months) Children (4 to 9 years) Adults (16 to 37 years) Elderly subjects (more than 70 years)
  • 9.
  • 10. Clearance increased from 0.9 to 2.5 ml/min. when comparing patient 1 to 8 days old with patient 9 to 30 days old.
  • 11. The mean clearance of ceftriaxone in children ranging in age from 1 to 12 months and from 1 to 6 years was 6.2 ml/min. and 9.1 ml/min. respectively.
  • 12.
  • 13.
  • 14. Most of the enzymatic microsomal systems required for drug metabolism are present at birth, but their concentration are usually lower than adult levels.
  • 15.
  • 16. Sulfate conjugation seems to be as efficient in newborns as in adults, but conjugation with glucuronic acid is considerably reduced, reaching adult level only after 3 years of age.
  • 17.
  • 18.
  • 19. In each case binding in plasma protein is level in the newborns than in the adults.
  • 20. Increase in plasma protein binding is an increase in apparent volume of distribution in the newborn.
  • 21.
  • 22.
  • 23. The difference process of renal excretion on mature at different rates,
  • 24. Average glomerular filtration rate is 38.5 ml/min.
  • 25.
  • 26.
  • 27. Older infants age (6 months to 12 years) has higher drug metabolism capacity rates compared to adults. for example, clindamycin theophylline valproic acid Has faster elimination rate.
  • 28.
  • 29. Formula used to determine dosage form
  • 30. Child dose= SA of child(m²) ------------------------------
  • 31.
  • 32. The increase in gastric ph, the decrease in gastric emptying rate and the slower motility associated with pregnancy can affect the rate and extent of drug absorption.
  • 33.